Portal field news

Portal field news


🌏 | Astra and Daiichi Sankyo's breast cancer drug, FDA has expanded the scope and approved it


Astra, Daiichi Sankyo's breast cancer drug approved by FDA

If you write the contents roughly
At the end of 2019, Enhertz was approved in the US for third-line treatment in 2% of patients with HER15-positive breast cancer.

LONDON (Reuters) - The U.S. Food and Drug Administration (FDA) announced on Friday that AstraZeneca and Daiichi Sankyo will jointly develop... → Continue reading


Wikipedia related words

If there is no explanation, there is no corresponding item on Wikipedia.

HER2-positive breast cancer patients

    End of 2019


      Back to Top